Thyroid hormone levels in patients with acute ischemic stroke and non-valvular atrial fibrillation

LU Yuanjun; LUAN Mei; FU Min; PAN Yumin; LIU Yanxi; SONG Jinling; ZENG Jiantao

doi:10.7619/jcmp.20233711

Journal of Clinical Medicine in Practice > 2024 > 28(8): 75-78. > DOI: 10.7619/jcmp.20233711

LU Yuanjun, LUAN Mei, FU Min, PAN Yumin, LIU Yanxi, SONG Jinling, ZENG Jiantao. Thyroid hormone levels in patients with acute ischemic stroke and non-valvular atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 75-78. DOI: 10.7619/jcmp.20233711

Citation:

PDF (925 KB)

Thyroid hormone levels in patients with acute ischemic stroke and non-valvular atrial fibrillation

1.
Department of Neurology, Changshou District People's Hospital of Chongqing, Chongqing, 401220
2.
Department of Laboratory Medicine, Changshou District People's Hospital of Chongqing, Chongqing, 401220

More Information

Received Date: November 18, 2023
Revised Date: January 22, 2024
Available Online: May 05, 2024

Graphical Abstract

Abstract

Abstract

Objective
To analyze the thyroid hormone levels in patients with acute ischemic stroke (AIS) and non-valvular atrial fibrillation (NVAF).
Methods
A total of 121 patients with AIS were selected, and were divided into NVAF group (AIS patients with NVAF) and control group (AIS patients without atrial fibrillation). Serum levels of triiodothyronine (T₃), free triiodothyronine (FT₃), thyroxine (T₄), free thyroxine (FT₄) and thyroid stimulating hormone (TSH) in two groups were measured and compared. The survival of the two groups was compared.
Results
The serum T₃ level in the NVAF group was significantly lower than that in the control group (P < 0.05). There were no significant differences in serum FT₃, T₄, FT₄ and TSH levels between the two groups (P>0.05). There was no significant difference in survival between the two groups (P>0.05).
Conclusion
NVAF is associated with serum T₃ levels in AIS patients. There is no correlation between the risk of death and NVAF in AIS patients.
- non-valvular atrial fibrillation,
- acute ischemic stroke,
- triiodothyronine,
- thyroid hormones

FullText(HTML)

References (24)

References

[1]	MA Q F, LI R, WANG L J, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021, 6(12): e897-e906. doi: 10.1016/S2468-2667(21)00228-0
[2]	FROST L, ANDERSEN L V, JOHNSEN S P, et al. Lost life years attributable to stroke among patients with nonvalvular atrial fibrillation: a nationwide population-based follow-up study[J]. Neuroepidemiology, 2007, 29 (1/2): 59-65.
[3]	中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. doi: 10.3760/cma.j.issn.1006-7876.2018.09.004
[4]	鲁远君, 付照平, 栾梅, 等. 急性缺血性脑卒中患者甲状腺激素与疾病严重程度及死亡的关系[J]. 临床内科杂志, 2022, 39(6): 400-402. doi: 10.3969/j.issn.1001-9057.2022.06.012
[5]	FRANCESCHI C, OSTAN R, MARIOTTI S, et al. The aging thyroid: a reappraisal within the geroscience integrated perspective[J]. Endocr Rev, 2019, 40(5): 1250-1270.
[6]	DUNTAS L H. Aging and the hypothalamic-pituitary-thyroid axis[J]. Vitam Horm, 2021, 115: 1-14.
[7]	CHEN J Y, LIPPO L, LABELLA R, et al. Decreased blood vessel density and endothelial cell subset dynamics during ageing of the endocrine system[J]. EMBO J, 2021, 40(1): e105242. doi: 10.15252/embj.2020105242
[8]	O'KEEFE L M, CONWAY S E, CZAP A, et al. Thyroid hormones and functional outcomes after ischemic stroke[J]. Thyroid Res, 2015, 8: 9. doi: 10.1186/s13044-015-0021-7
[9]	DAVIS P J, GLINSKY G V, LIN H Y, et al. Actions of thyroid hormone analogues on chemokines[J]. J Immunol Res, 2016, 2016: 3147671.
[10]	卓蕊, 李结华. 高龄非瓣膜性心房颤动患者的抗凝治疗探讨[J]. 实用临床医药杂志, 2020, 24(12): 42-44. doi: 10.7619/jcmp.202012012
[11]	BOURSIER-BOSSY V, ZUBER M, EMMERICH J. Ischemic stroke and non-valvular atrial fibrillation: when to introduce anticoagulant therapy[J]. J Med Vasc, 2020, 45(2): 72-80.
[12]	WANKOWICZ P, NOWACKI P, GOŁAB-JANOWSKA M. Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range[J]. Arch Med Sci, 2019, 15(5): 1217-1222. doi: 10.5114/aoms.2018.77546
[13]	WANG L L, ZHANG Y. Role of hyperhomocysteine, thyroid dysfunction and their interaction in ischemic stroke patients with non-valvular atrial fibrillation[J]. Sci Rep, 2020, 10(1): 12419. doi: 10.1038/s41598-020-69449-2
[14]	BUNEVICIUS A, IERVASI G, BUNEVICIUS R. Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders[J]. Expert Rev Neurother, 2015, 15(3): 315-326. doi: 10.1586/14737175.2015.1013465
[15]	LIU J F, WANG D R, XIONG Y, et al. Low free triiodothyronine levels are related to symptomatic intracranial hemorrhage and poor functional outcomes after intravenous thrombolysis in acute ischemic stroke patients[J]. Neurol Res, 2016, 38(5): 429-433. doi: 10.1080/01616412.2016.1178480
[16]	BASHYAL S, GORKHALY M P, DEVKOTA R, et al. Alteration of Thyroid Hormone among Patients with Ischemic Stroke visiting a Tertiary Care Hospital: a Descriptive Cross-sectional Study[J]. JNMA J Nepal Med Assoc, 2021, 59(240): 779-782. doi: 10.31729/jnma.6501
[17]	SIDOROV E, PAUL A, XU C, et al. Decrease of thyroid function after ischemic stroke is related to stroke severity[J]. Thyroid Res, 2023, 16(1): 28. doi: 10.1186/s13044-023-00160-w
[18]	SUDA S, SHIMOYAMA T, NAGAI K, et al. Low free triiodothyronine predicts 3-month poor outcome after acute stroke[J]. J Stroke Cerebrovasc Dis, 2018, 27(10): 2804-2809. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.009
[19]	THYGESEN S K, FROST L, EAGLE K A, et al. Atrial fibrillation in patients with ischemic stroke: a population-based study[J]. Clin Epidemiol, 2009, 1: 55-65.
[20]	FERNANDES L, SARGENTO-FREITAS J, MILNER J, et al. Ischemic stroke in patients previously anticoagulated for non-valvular atrial fibrillation: why does it happen[J]. Rev Port Cardiol, 2019, 38(2): 117-124. doi: 10.1016/j.repc.2018.06.004
[21]	CHAN Y H, LEE H F, CHAO T F, et al. Real-world comparisons of direct oral anticoagulants for stroke prevention in Asian patients with non-valvular atrial fibrillation: a systematic review and meta-analysis[J]. Cardiovasc Drugs Ther, 2019, 33(6): 701-710. doi: 10.1007/s10557-019-06910-z
[22]	PAPALEONTIOU M, LEVINE D A, REYES-GASTELUM D, et al. Thyroid hormone therapy and incident stroke[J]. J Clin Endocrinol Metab, 2021, 106(10): e3890-e3900. doi: 10.1210/clinem/dgab444
[23]	MUROLO M, VINCENZO O D, CICATIELLO A G, et al. Cardiovascular and neuronal consequences of thyroid hormones alterations in the ischemic stroke[J]. Metabolites, 2022, 13(1): 22. doi: 10.3390/metabo13010022
[24]	TALHADA D, SANTOS C R A, GONÇALVES I, et al. Thyroid hormones in the brain and their impact in recovery mechanisms after stroke[J]. Front Neurol, 2019, 10: 1103.

[1]	WANG Mingbang, CHEN Changsha, LIU Rongzhen, XU Jianfeng. Effect of transurethral plasmakinetic resection of prostate in treating benign prostatic hyperplasia complicated with hypertension[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 90-94. DOI: 10.7619/jcmp.20241211
[2]	LI Meng, ZHANG Wenfeng, WU Wenfeng, JIANG Tao, WEN Lili. Transurethral green laser enucleation of prostate versus transurethral vaporization of prostate in treatment of severe benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 113-116, 121. DOI: 10.7619/jcmp.20214804
[3]	WU Haoming, FU Guangbo. Clinical significance of long non-coding RNA SChLAP1 expression in prostate cancer tissue and its relationship with prognosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 30-33. DOI: 10.7619/jcmp.20214427
[4]	PAN Kai, SHEN Yuyong, ZHOU Hai, CHEN Yuming, QI Lezhong, FAN Qibing, QI Tingyue, WANG Xiaoxiang. Modified holmium laser enucleation of the prostate versus transurethral resection of prostate in treatment patients with large volume prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 21-24. DOI: 10.7619/jcmp.202011006
[5]	DONG Xinqiang, SUN Wengong, CUI Hongquan, PENG Yingke. Effect of dilatation surgery of prostate on sexual function in benign prostatic hyperplasia patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 65-67. DOI: 10.7619/jcmp.202002019
[6]	ZHANG Shaojie, XU Xiaofeng, DU Quan, LI Nan, XIAO Xiang. Effect of transurethral plasma bipolar resection of prostate on urodynamics and serum levels of prostate specific antigen, epidermal growth factor and prostaglandin E₂ in patients with benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2019, 23(18): 79-83. DOI: 10.7619/jcmp.201918023
[7]	ZENG Hanyun. Clinical nursing pathway in treating benign prostatic hyperplasia patients with transurethral resection[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 123-125, 128. DOI: 10.7619/jcmp.201913035
[8]	ZHOU Cuiyu, LIU Weihua. Evidence-based nursing for transurethral resection of prostate in elderly patients underwent benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 116-120. DOI: 10.7619/jcmp.201907031
[9]	WANG Yongheng, ZHANG Xueguang. Effect of transurethral plasma prostate gland resection on the treatment of benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2018, (7): 99-101. DOI: 10.7619/jcmp.201807027
[10]	LUO Qing, JIANG Jinxiong, CAO Xiaozhen, XIAO Qinghua. Differential diagnostic value of transrectal ultrasound combined with PSAD on prostate cancer and benign prostate hyperplsia[J]. Journal of Clinical Medicine in Practice, 2013, (13): 156-158. DOI: 10.7619/jcmp.201313057

Cited By

Cited by

Periodical cited type(2)

1.	喻洁明，任荣飞，陈晓亮. 耳内镜下应用耳屏软骨-软骨膜复合体行Ⅰ型鼓室成形术的临床疗效研究. 中国医学文摘(耳鼻咽喉科学). 2024(01): 130-132+108 .
2.	包勇正，邹文兰，胡志邦，马敬. 29例鼓膜大穿孔患者耳内镜下鼓膜成形术疗效观察. 实用临床医药杂志. 2020(23): 42-44 . 本站查看

Other cited types(0)

Get Citation

PDF

XML

Article views (100) PDF downloads (5) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Thyroid hormone levels in patients with acute ischemic stroke and non-valvular atrial fibrillation